Tag Archives: antitrust

Congressional Hearings on Federal Health Policies

A number of recent Congressional hearings focused on federal health policies, including the following: House Energy and Commerce Committee hearings on the impact of health care consolidation, oversight of the Department of Health and Human Services (including the Trump Administration’s HHS budget request), and drug compounding. Ways and Means Committee hearings on President Trump’s HHS … Continue Reading

House Overwhelmingly Approves Insurance Antitrust Reform Legislation

The House of Representatives has approved HR 372, the Competitive Health Insurance Reform Act of 2017, which would repeal the antitrust exemption for health insurance companies provided under the McCarran-Ferguson Act (although the antitrust exemption for certain collaborative activities between health insurance businesses would be retained). HR 372 was approved by a vote of 416-7, … Continue Reading
LexBlog